Jindal K C, Chaudhary R S, Singla A K, Gangwal S S, Khanna S
Lupin Laboratories Limited, M.I.D.C., Aurangabad, India.
J Pharm Biomed Anal. 1994 Apr;12(4):493-7. doi: 10.1016/0731-7085(94)80030-8.
A dissolution procedure for a rifampicin-isoniazid combination formulation was evaluated using 0.1 N hydrochloric acid solution and 0.4% (w/v) sodium lauryl sulphate solution as dissolution media. Rifampicin and isoniazid along with degradation components were chromatographed using reversed-phase liquid chromatography on a 10 microns octadecylsilica column using methanol-0.01 M disodium hydrogen phosphate (70:30, v/v; pH 4.6 +/- 0.1) as mobile phase. The detection was carried out at 254 nm. The data obtained indicate that the dissolution medium consisting of 0.4% (w/v) sodium lauryl sulphate solution is suitable for such a combination. The degradation observed in dissolution medium consisting of 0.1 N hydrochloric acid was 10-23%.
使用0.1 N盐酸溶液和0.4%(w/v)十二烷基硫酸钠溶液作为溶出介质,对利福平-异烟肼复方制剂的溶出度测定方法进行了评估。利福平、异烟肼及其降解成分采用反相液相色谱法,在10微米十八烷基硅胶柱上进行分离,流动相为甲醇-0.01 M磷酸氢二钠(70:30,v/v;pH 4.6±0.1),检测波长为254 nm。所得数据表明,由0.4%(w/v)十二烷基硫酸钠溶液组成的溶出介质适用于该复方制剂。在0.1 N盐酸组成的溶出介质中观察到的降解率为10%-23%。